1. Home
  2. ARVN vs RWT Comparison

ARVN vs RWT Comparison

Compare ARVN & RWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$9.20

Market Cap

516.2M

Sector

Health Care

ML Signal

HOLD

Logo Redwood Trust Inc.

RWT

Redwood Trust Inc.

HOLD

Current Price

$4.80

Market Cap

574.0M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARVN
RWT
Founded
2015
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
516.2M
574.0M
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
ARVN
RWT
Price
$9.20
$4.80
Analyst Decision
Buy
Buy
Analyst Count
19
7
Target Price
$15.05
$6.82
AVG Volume (30 Days)
878.8K
1.9M
Earning Date
05-04-2026
04-29-2026
Dividend Yield
N/A
12.83%
EPS Growth
58.84
N/A
EPS
1.70
N/A
Revenue
$262,600,000.00
N/A
Revenue This Year
N/A
$26.59
Revenue Next Year
N/A
$22.21
P/E Ratio
$5.28
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.96
$4.19
52 Week High
$14.22
$6.97

Technical Indicators

Market Signals
Indicator
ARVN
RWT
Relative Strength Index (RSI) 64.01 52.63
Support Level $7.90 $4.44
Resistance Level $9.65 $4.97
Average True Range (ATR) 0.40 0.15
MACD 0.07 0.03
Stochastic Oscillator 75.50 97.37

Price Performance

Historical Comparison
ARVN
RWT

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

About RWT Redwood Trust Inc.

Redwood Trust Inc is a specialty finance company focused on several distinct areas of housing credit. The company delivers customized housing credit investments to a diverse mix of investors through securitization platforms, whole-loan distribution activities, and its publicly traded securities. The company has four reportable segments: Sequoia Mortgage Banking, CoreVest Mortgage Banking, Redwood Investments, and Legacy Investments. Maximum revenue is generated from the Sequoia Mortgage Banking segment, comprising a mortgage loan conduit that acquires residential consumer loans from third-party originators for subsequent sale to whole loan buyers, securitization through its SEMT private-label securitization program, or transfer into its Redwood Investments portfolio.

Share on Social Networks: